THE PATHOPHYSIOLOGY OF CUTANEOUS MANIFESTATIONS RELATED TO COVID-19
Main Article Content
Abstract
Covid-19 is a respiratory infection caused by the newly emerging coronavirus. Covid-19 can also cause skin abnormalities, although the pathophysiology of manifestations of skin disorders associated with Covid-19 has not been understood with certainty. This study aims to discuss the pathophysiology of cutaneous manifestation related to Covid-19. The study was conducted based on literature and data mining related to Covid-19 using PubMed and Google Scholar. Eligible papers provided pathophysiology of cutaneous manifestations related to Covid-19. Papers not available in English were excluded. As a result of the presence of edema, vasodilation, and cellular infiltration, skin lesions such as rash, urticarial, or extensive purpura, or even thrombosis and haemorrhage, arise if damage to the vessels became severe. The pathophysiology of Covid-19-associated skin manifestations is estimated through some different mechanisms, such as lesions found in various Covid-19 patients, namely, the presence of varicella such as eruption, non-characteristic rash, and urticarial. Further studies are required to establish a Covid-19 diagnosis based on skin manifestations.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
a). Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Attribution-NonCommercial-ShareAlike 4.0 International that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b). Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c). Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
References
Biswas A, Bhattacharjee U, Chakrabarti AK, Tewari DN, Banu H, Dutta S (2020) Emer-gence of novel coronavirus and COVID-19: Whether to stay or die out? Crit Rev Micro-biol 46:182-193.
Cava C, Bertoli G, Castiglioni I (2020) In silico discovery of candidate drugs against covid-19. Viruses 12: 404.
Darlenski R, Tsankov N (2020) Covid-19 pandemic and the skin - What should derma-tologists know? Clin Dermatol 38: 785-787.
Drago F, Ciccarese G, Gasparini G, Cogor-no L, Javor S, Toniolo A, et al (2017) Con-temporary infectious exanthems: An update. Future Microbiol 12: 171-193.
Estébanez A, Pérez-Santiago L, Silva E, Guillen-Climent S, García-Vázquez A, Ramón MD (2020) Cutaneous mani-festations in Covid-19: A new contri-bution. J Eur Acad Dermatol Venereol 34: e250-e251.
Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H (2004) Tis-sue distribution of ACE2 protein: The functional receptor for SARS corona-virus. A first step in understanding SARS pathogenesis. J Pathol 203: 631-637.
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al (2020) SARS-CoV-2 cell entry de-pends on ACE2 and TMPRSS2 and is blocked by a clinically proven prote-ase inhibitor. Cell 181: 271-80.e8.
Recalcati S (2020) Cutaneous manifesta-tions in COVID-19: A first perspective. J Eur Acad Dermatol Venereol 3: e212-e213.
Schoeman D, Fielding BC (2019) Corona-virus envelope protein: Current knowledge. Virol J 16: 1-22.